January/February

home / publications / evidence-based-oncology / 2013-1-vol19-sp1

Literature Review: Melanoma

February 26th 2013

ArticleEvidence-Based Oncology

Crossroads in Breast Cancer: The Intersection of Clinical Uncertainty and Molecular Profiling

Kim Farina, PhD

February 26th 2013

ArticleEvidence-Based Oncology

ASH Conference Coverage

February 26th 2013

ArticleEvidence-Based Oncology

Managed Care Restrictions: Barriers to Product Use in Cancer Care

February 26th 2013

ArticleEvidence-Based Oncology

Partial Fill Strategies for Oral Oncolytics to Reduce Waste and Drive Persistency

Atheer A. Kaddis, PharmD

February 26th 2013

ArticleEvidence-Based Oncology

From Bench to Bedside: Promising Colon Cancer Clinical Trials

Jill M. Comeau, PharmD, BCOP;Brice Labruzzo Mohundro, PharmD, BCACP

February 26th 2013

ArticleEvidence-Based Oncology

The Future of Oncology? COME HOME, the Oncology Medical Home

Barbara L. McAneny, MD

February 26th 2013

ArticleEvidence-Based Oncology

Focusing on Clinical and Economic Outcomes-Not Guidelines

Is It Time for a New Direction in Oncology Care?

February 26th 2013

ArticleEvidence-Based Oncology

Interview With Andrew Pecora, MD, CPE, President, Regional Cancer Care Associates, Chief Innovations Officer and Vice President, Cancer Services, John Theurer Cancer Center at Hackensack University Medical Center

The Role of Companion Diagnostic Testing in Payer Decision Making

February 26th 2013

ArticleEvidence-Based Oncology

Literature Review: Chronic Myeloid Leukemia

February 26th 2013

ArticleEvidence-Based Oncology

Lessons From an Oncology Medical Home Collaborative

John Fox, MD, MHA

February 25th 2013

ArticleEvidence-Based Oncology

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions